Recent News

• 10.03.2025 - Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 10.03.2025 - Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 10.03.2025 - Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 10.03.2025 - Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 09.09.2025 - Fireside Chat at H.C. Wainwright Global Investment Conference
• 09.09.2025 - Fireside Chat at H.C. Wainwright Global Investment Conference
• 09.09.2025 - Fireside Chat at H.C. Wainwright Global Investment Conference
• 09.09.2025 - Fireside Chat at H.C. Wainwright Global Investment Conference
• 09.03.2025 - Fireside Chat at Cantor Fitzgerald Global Healthcare Conference
• 09.03.2025 - Fireside Chat at Cantor Fitzgerald Global Healthcare Conference

Recent Filings

• 10.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.11.2025 - 144 Report of proposed sale of securities
• 08.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.28.2025 - 144 Report of proposed sale of securities